Form 4: Alzamend Neuro Director William B. Horne Reports Transaction in Company Stock
SEC Form 4 Filing
Director William B. Horne reports the acquisition and disposal of Alzamend Neuro, Inc. (ALZN) common stock on March 26, 2025.
Summary
- On March 26, 2025, William B. Horne, a director of Alzamend Neuro, Inc. (ALZN), reported a transaction involving the company's common stock.
- Horne acquired 3,334 shares of common stock at a price of $0.9854 per share.
- Horne disposed of 30,000 shares of common stock.
- The filing indicates Horne's direct ownership of the securities.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It allows investors to monitor the actions of those with privileged information.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the trading activity of a company director.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of stock transaction (acquisition and disposal). |
| 03/27/2025 | Date of signature on the Form 4 filing. |
Keywords
Alzamend Neuro, ALZN, Form 4, William B. Horne, Director, Stock Transaction, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.